The Future Role of 3D Printing in Personalized Medicines
On the last day of CPhI Worldwide (Thursday Nov. 7, 2019), several experts will examine the potential role of three-dimensional printing within medicines, particularly in light of the shift in the industry from volume to value.
On the last day of CPhI Worldwide (Thursday Nov. 7, 2019), several experts will examine the potential role of three-dimensional printing within medicines, particularly in light of the shift in the industry from volume to value.
As smaller patient populations are being addressed by companies and more personalized and complex therapeutic solutions and being favored, exploration of alternative technologies, such as 3D printing, are being explored. In the panel discussion, several experts will look at the current capabilities and future potential of 3D printing technologies, the potential impact the technology may have on personalized medicines, an overview of technologies currently available, and they will present a case study on the subject matter.
Included on the panel will be Dr. Alvaro Goyanes (FabRx), Beau Jackson (3D Printing Industry), Craig Johnston (EMAC Future Manufacturing Research Hub), Ian Rees (Medicines and Healthcare products Regulatory Agency), and Jae Yoo (Aprecia Pharmaceuticals).
Made to Order: 3D Printing for Personalized Medicines
Thursday Nov. 7, 2019
10:30–11:40
ICSE Theatre (120G43)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
